Clinical trial Recruiting at 1 site Observational Ages 18 to 45 Women only

Using echocardiography to diagnose fetal growth issues in twin pregnancies

Official title: Speckle Tracking Echocardiography as a Tool for Early Diagnosis of Impaired Fetal Growth in Twin Pregnancies

Run by University Hospital, Ghent · NCT05423665 · Data updated 2026-11-12

This study is testing if a special heart ultrasound can help doctors spot growth problems in twins before they are born, while also looking at how air pollution might affect their health.

Quick facts

Study typeObservational
Ages18 Years to 45 Years
SexWomen only
Enrollment360 (estimated)
SponsorUniversity Hospital, Ghent
Academic / other
Locations3 sites (Ghent and 2 other locations)
StatusRecruiting
StartedJune 22, 2023
Main results expectedFebruary 1, 2027
Study endsFebruary 1, 2028
Registry record updatedSeptember 21, 2026
Trial IDNCT05423665 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are pregnant women with singleton or dichorionic twin pregnancies who are around 21 weeks of gestation.

Probably not a fit

Patients who are pregnant with higher-order multiples (three or more) or have known fetal congenital abnormalities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the effectiveness of speckle tracking echocardiography (STE) in diagnosing fetal growth restriction (FGR) in twin pregnancies at two key gestational points: 21 weeks and 30 weeks. It will involve measuring fetal growth parameters, assessing maternal exposure to air pollution, and analyzing placental and umbilical cord blood samples to understand their relationship with FGR. The study will also explore the potential link between air pollution exposure and cardiac remodeling in fetuses. By integrating these assessments, the research seeks to improve early detection and management of FGR, which is crucial for reducing perinatal morbidity and mortality.

Why it matters

Potential benefit: If successful, this study could lead to earlier and more accurate diagnoses of fetal growth restriction, improving outcomes for twin pregnancies.

How similar studies have gone: While the use of speckle tracking echocardiography in pregnancy is relatively novel, similar studies have shown promising results in other contexts, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Singleton or dichorionic twin pregnancy
* Pregnant women 21 weeks ( ± 2 weeks) of gestation at the first visit
* Women ≥ 18 years

Exclusion Criteria:

* Women pregnant of multiples of higher order (≥3 siblings) Monochorionic twin pregnancy
* Fetal arrhythmia
* Known fetal congenital or genetic abnormalities
* Any suspicion of congenital fetal anomalies that might influence fetal cardiac function
* Pre-existing maternal hypertensive disease
* Autoimmune disease including systemic lupus erythematosus
* History of stillbirth
* Diabetes mellitus (mother)

Where it's running

  • Ghent University Hospital
    Ghent, Belgium
    Recruiting
  • Universitair ziekenhuis Leuven
    Leuven, Belgium
    Not yet recruiting
  • Maxima medical center
    Eindhoven, Netherlands
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Ophthalmic Artery Doppler to predict labor problems before induction

    This study tests whether measuring the ophthalmic artery Doppler in pregnant people at term who are being induced can help predict intrapartum fetal distress.

    Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Rome, rm · NCT07846137

  • Fetal Heart Function in Growth-Restricted Pregnancies

    This study tests whether fetal echocardiography using a modified Tei index (Mod-MPI) can reveal early heart changes in pregnancies affected by fetal growth restriction (IUGR).

    Recruiting Assiut University · Asyut · NCT07760194

  • How weather and air pollution affect physical activity in Shenyang and Shenzhen

    This project will test whether differences in weather and air pollution change how much physical activity adults aged 18 to 55 do in Shenyang and Shenzhen.

    Recruiting at 2 sites Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences · Shenzhen, Guangdong and 1 other locations · NCT07523659

  • Personalized placental risk assessment to customize pregnancy care

    This project will try to build a tool that uses pregnancy ultrasound and blood tests to predict placental insufficiency for people with a single pregnancy who plan to deliver at OHSU.

    Recruiting Oregon Health and Science University · Portland, Oregon · NCT07144839

  • Pravastatin for severe early-onset placental insufficiency

    This trial will test whether pravastatin can safely prolong pregnancy and lower risks for pregnant people with severe early-onset preeclampsia or early-onset IUGR between 24+0 and 29+6 weeks.

    Recruiting Phase 2 Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Barcelona, Barcelona and 1 other locations · NCT07098975

  • Combined first-trimester screening for pregnancy complications

    This project tests a standardized first-trimester screening to see if it can identify pregnant women at 11–13 weeks who are at higher risk for preeclampsia, fetal growth restriction, chromosomal problems, and other serious complications.

    Recruiting at 3 sites Institute of Health Information and Statistics of the Czech Republic · Most, Czechia and 2 other locations · NCT07015203

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.